Translational Centers Using Microphysiologic Systems for Infectious Diseases
This grant supports developing human microphysiologic systems to study infectious diseases and advance drug or biologic product development, aiming to reduce animal testing and improve regulatory acceptance.
Funder: National Institutes of Health
Due Dates (Anticipated): January 2027 (Full application deadline, projected)
Funding Amounts: $7,000,000 total program funding; approximately 5 awards expected; typical duration 1 year
Summary: Supports translational centers developing human microphysiologic systems (MPS) for infectious disease research and product development to advance alternatives to animal models.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
Description
This forecasted opportunity from the National Institute of Allergy and Infectious Diseases (NIAID) aims to accelerate the development and adoption of human microphysiologic systems (MPS) for infectious disease research and the development of therapeutics or biological products. MPS are in vitro platforms designed to mimic physiological aspects of human tissues or organs, offering alternatives to animal models. The program seeks to promote the use of MPS in studies of infectious diseases, facilitate product development, and encourage regulatory acceptance by drug and biologic developers.
